Skip to main content
Critical Care

Hepatic Encephalopathy: Why Does Liver Disease Change Mental Status?

If you’re trying to connect liver failure with a change in consciousness, start with the route from the gut to the brain. Hepatic encephalopathy can develop when the liver isn’t processing substances normally or when blood bypasses it through portosystemic shunts. Substances that affect the brain can then accumulate. Ammonia is part of the mechanism, along with inflammation and other changes. But an elevated ammonia result alone doesn’t tell you that hepatic encephalopathy is the cause of a patient’s confusion.

S

Sachi, CRNA

CRNA

Last updated ·3 min read
CRNA Club study guide: Hepatic Encephalopathy: Why Does Liver Disease Change Mental Status?
In This Article (7 sections)

Use the hepatic and multisystem lessons in the CCRN Toolkit to work through that reasoning. It’s a separate paid offer. The seven-day platform trial adds the broader learning library and clinical interview tools.

How does the gut connect with the brain?

The gut and other tissues produce ammonia as the body processes nitrogen. The liver converts much of it into urea, which the kidneys excrete.

Now what if the liver isn’t doing that work well? Ammonia processing falls. With portosystemic shunting, some blood bypasses the liver, so substances in it reach the rest of the circulation without the usual hepatic processing.

In the brain, ammonia metabolism in astrocytes contributes to glutamine accumulation and altered cell function. Astrocytes are supporting cells in the brain. So the effect isn’t only “a blood value went up.” Brain-cell function is changing.

In acute liver failure, cerebral edema—brain swelling—is a major concern. Don’t carry that over as the same degree or mechanism of swelling in every patient with cirrhosis and confusion.

If ammonia is involved, why can’t the number diagnose it?

Well, the blood result doesn’t reliably track clinical severity in cirrhosis. Measurement also depends on sample handling and laboratory methods.

AASLD’s explanation of ammonia testing emphasizes clinical assessment and the limits of an isolated elevated result. You still need to assess consciousness and other possible causes.

What if ammonia is normal when you suspect overt hepatic encephalopathy? Reevaluate the diagnosis rather than ignoring the result.

Practice that explanation with the CCRN Toolkit: ammonia can contribute to the mechanism without one measured level identifying the cause or grading the patient’s condition.

What might have triggered the change?

Look at what happened before mental status worsened. Was there infection or gastrointestinal bleeding? Constipation? Dehydration, an electrolyte disturbance or a sedating medication?

A GI bleed adds nitrogen from blood in the gut. Constipation keeps intestinal contents there longer. Infection adds inflammatory stress. More than one contributor can be present.

The hepatic encephalopathy reference discusses these triggers and the evaluation. Finding one gives the treatment plan a specific problem to address.

How do you keep the assessment open?

Consider a fictional patient with cirrhosis who becomes confused after several days of constipation. The patient also has a fever and received a sedating medication.

Constipation makes hepatic encephalopathy plausible. But fever still needs an infection assessment, and the medication could also reduce alertness. An elevated ammonia result doesn’t make those questions disappear.

Compare with baseline. Check the current examination, glucose and respiratory status, along with the other relevant findings. What changed, and what needs urgent attention?

Asterixis can support the pattern, but it isn’t unique to hepatic encephalopathy. Use the examination to investigate instead of letting one finding end it.

Why use lactulose or rifaximin?

They work on the intestinal part of the problem. Lactulose changes ammonia handling in the gut and promotes elimination. Rifaximin reduces ammonia-producing intestinal bacterial activity. Their roles depend on the treatment and recurrence-prevention plan.

Follow how the patient is doing, the triggers you’ve identified and the response to that plan. Don’t chase an ammonia number while consciousness worsens.

Watch for excessive diarrhea and volume loss too. More bowel output isn’t automatically better treatment if it creates another problem for the patient.

Our Final Thoughts

Follow the gut-to-liver-to-brain pathway, then try explaining why the fictional patient’s fever and medication still need attention. It’s okay to return to that connection more than once. Understanding the mechanism should help you ask better questions about the confusion, not close the assessment too soon.

Give another hepatic case a careful read

Use the hepatic lessons and questions in the CCRN Toolkit to practice connecting a trigger with the patient findings. For wider clinical learning and interview tools, explore the seven-day platform trial.

Tags:CRNA schoolhepatic encephalopathy pathophysiology

Frequently Asked Questions

Does high ammonia prove hepatic encephalopathy?

No. In cirrhosis, an elevated result alone does not identify the cause of confusion or its clinical severity. Assess the patient and the other possible causes.

Can shunting cause encephalopathy without the same degree of liver damage?

Portosystemic shunts let blood bypass hepatic processing, which can contribute to encephalopathy. Interpret that with the type of shunt and the rest of the patient’s condition.

Why does gastrointestinal bleeding trigger encephalopathy?

Blood in the gut adds a nitrogen load. In a susceptible patient, that can contribute to ammonia production along with the other effects of the bleed.

Is asterixis specific to hepatic encephalopathy?

No. Other metabolic and drug-related conditions can cause it too. Use it as part of the examination, not as a diagnosis by itself.

Should treatment follow serial ammonia values alone?

No. Follow mental status, identified triggers and the prescribed plan. AASLD explains the limits of ammonia monitoring in chronic liver disease.